Publicaciones en colaboración con investigadores/as de Centro de Investigación y Tecnología Agroalimentaria de Aragón (26)

2022

  1. A Brucella melitensis H38ΔwbkF rough mutant protects against Brucella ovis in rams

    Veterinary research, Vol. 53, Núm. 1, pp. 16

2021

  1. Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle

    PLoS ONE, Vol. 16, Núm. 11 November

  2. The Phospholipid N-Methyltransferase and Phosphatidylcholine Synthase Pathways and the ChoXWV Choline Uptake System Involved in Phosphatidylcholine Synthesis Are Widely Conserved in Most, but Not All Brucella Species

    Frontiers in Microbiology, Vol. 12

2020

  1. Development of attenuated live vaccine candidates against swine brucellosis in a non-zoonotic B. suis biovar 2 background

    Veterinary Research, Vol. 51, Núm. 1

  2. Glucose Oxidation to Pyruvate Is Not Essential for Brucella suis Biovar 5 Virulence in the Mouse Model

    Frontiers in Microbiology, Vol. 11

2018

  1. Identification of lptA, lpxE, and lpxO, three genes involved in the remodeling of Brucella cell envelope

    Frontiers in Microbiology, Vol. 8, Núm. JAN

2016

  1. A review of the basis of the immunological diagnosis of ruminant brucellosis

    Veterinary Immunology and Immunopathology, Vol. 171, pp. 81-102

2014

  1. Elucidating Sources and Roles of Granzymes A and B during Bacterial Infection and Sepsis

    Cell Reports, Vol. 8, Núm. 2, pp. 420-429

  2. Performance of skin tests with allergens from B. melitensis B115 and rough B. abortus mutants for diagnosing swine brucellosis

    Veterinary Microbiology, Vol. 168, Núm. 1, pp. 161-168

2011

  1. Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen- associated molecular pattern

    PLoS ONE, Vol. 6, Núm. 1

2010

  1. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams

    Vaccine, Vol. 28, Núm. 17, pp. 3038-3046

2009

  1. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep

    Vaccine, Vol. 27, Núm. 11, pp. 1741-1749

2008

  1. Brucellosis vaccines: Assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export

    PLoS ONE, Vol. 3, Núm. 7

2007

  1. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence

    Infection and Immunity, Vol. 75, Núm. 10, pp. 4867-4874

2006

  1. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams

    Vaccine, Vol. 24, Núm. 11, pp. 1897-1905

  2. Encapsulation of antigenic extracts of Salmonella enterica serovar. Abortusovis into polymeric systems and efficacy as vaccines in mice

    Veterinary Microbiology, Vol. 118, Núm. 1-2, pp. 124-132

  3. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice

    Vaccine, Vol. 24, Núm. 19, pp. 4179-4187

  4. Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1 [13]

    Clinical Chemistry

2005

  1. Restriction site polymorphisms in the genes encoding new members of group 3 outer membrane protein family of Brucella spp.

    FEMS Microbiology Letters, Vol. 245, Núm. 1, pp. 79-84

2004

  1. Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis

    International Journal of Pharmaceutics, Vol. 271, Núm. 1-2, pp. 125-135